Q2 FY2026 · ended Jun 30, 2026 · Revenue $126.12M, -0.9% YoY · Filed Aug 12, 2026
Ascend Wellness Holdings, Inc. (AAWH) files with the SEC under industry code 2833, Medicinal Chemicals & Botanical Products. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $126.1 million and a net loss of $9.8 million. Free cash flow was $16.7 million. As of Jun 30, 2026 it held $67.0 million in cash and investments and $652.7 million in total debt.
Revenue
$126.12M
-0.9% vs year-ago quarter
Net income
$-9.81M
+59.8% vs year-ago quarter
Operating cash flow
$22.45M
+26.1% vs year-ago quarter
Free cash flow
$16.67M
+44.3% vs year-ago quarter
EPS
$-0.05
+58.3% vs year-ago quarter
Dividend per share
None
Shares outstanding
203.21M
+0.1% vs prior quarter
Net cash
$-585.72M
Q2 FY2026
Operating margin
-2.2%
TTM
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- AAWH (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Rochelle Park, NJ
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1756390
- Former names
- Ascend Wellness Holdings, Inc (until Mar 11, 2022); Ascend Wellness Holdings, LLC (until Apr 15, 2021)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $126.1M | $116.9M | $120.5M | $124.7M | $127.3M |
| Operating income | $5.3M | $2.5M | -$17.2M | -$1.3M | -$1.0M |
| Net income | -$9.8M | -$29.5M | -$48.7M | -$25.8M | -$24.4M |
| Diluted EPS | -$0.05 | -$0.15 | -$0.24 | -$0.13 | -$0.12 |
| Operating cash flow | $22.5M | -$19.4M | $16.3M | -$2.0M | $17.8M |
| Free cash flow | $16.7M | -$24.6M | $9.4M | -$8.5M | $11.6M |
| Total assets | $888.3M | $872.1M | $907.9M | $900.4M | $903.9M |
| Total liabilities | $973.4M | $947.9M | $954.5M | $897.8M | $875.7M |
| Stockholders' equity | -$85.9M | -$76.6M | -$47.4M | $1.8M | $27.3M |
| Cash and investments | $67.0M | $60.9M | $85.7M | $87.3M | $95.3M |
| Total debt | $652.7M | $629.3M | $629.6M | $636.4M | $620.8M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Shareholder vote results
|
Aug 31, 2026 | Aug 28, 2026 |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jun 25, 2026 | Jun 24, 2026 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 13, 2026 | May 13, 2026 |
All 147 Ascend Wellness Holdings, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.